Reprogrammed Interchange LLC sells 447,278 VOR shares at $1.54 weighted average

Rhea-AI Filing Summary

Vor Biopharma Inc. (VOR) insiders reported a sale of common stock on 09/16/2025. Reprogrammed Interchange LLC executed multiple trades selling 447,278 shares at a weighted average price of $1.5401, with trade prices ranging from $1.52 to $1.58. After the reported sale, the amount of shares beneficially owned by Reprogrammed is 32,781,209 shares and the ownership is listed as direct. Reid Hoffman is separately reported as a director and may be deemed a beneficial owner of the shares held by Reprogrammed due to shared control and indirect pecuniary interest, though he disclaims beneficial ownership except to the extent of his pecuniary interest. The Form 4 was signed on 09/18/2025 by Reid Hoffman and Frank Huang, Manager of Reprogrammed Interchange LLC.

Positive

• Transparent disclosure of weighted average sale price and price range ($1.52–$1.58)
• Full Form 4 signatures from Reid Hoffman and manager Frank Huang, indicating proper execution
• Clear explanation of reporting relationships and disclaimer of beneficial ownership by Reid Hoffman

Negative

• Insider sale of 447,278 shares could be viewed negatively by investors depending on context
• No information provided in this filing about total outstanding shares or percentage sold, limiting materiality assessment

Insights

Financial Analyst

TL;DR: Director-linked entity sold 447,278 shares at ~$1.54; transaction disclosed transparently, impact uncertain without total float context.

The filing shows a sizable block sale executed by Reprogrammed Interchange LLC on 09/16/2025, reported as 447,278 shares at a weighted average price of $1.5401. The seller remains a direct holder of 32,781,209 shares after the disposition. The disclosure notes trade-level prices between $1.52 and $1.58 and offers to provide detailed trade breakdowns on request, which supports transparency. Without information on total outstanding shares or recent trading volume, the market impact and relative size of the sale cannot be assessed from this filing alone.

Corporate Governance Expert

TL;DR: Director-related entity reported sale with appropriate disclosure and a statement disclaiming full beneficial ownership by the director.

The Form 4 identifies both Reprogrammed Interchange LLC and Reid Hoffman as reporting persons and marks them as directors and 10% owners. The explanatory note clarifies that Mr. Hoffman may be deemed a beneficial owner due to shared control of Reprogrammed but disclaims ownership except for pecuniary interest. Signatures are provided, and the filing follows required disclosure conventions. This properly notifies investors of insider selling while clarifying the reporting person relationships.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Reprogrammed Interchange LLC

(Last) (First) (Middle)

101 MISSION STREET, SUITE 1000

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vor Biopharma Inc. [ VOR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/16/2025		S		447,278	D	$1.5401(1)	32,781,209(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

Reprogrammed Interchange LLC

(Last) (First) (Middle)

101 MISSION STREET, SUITE 1000

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Hoffman Reid

(Last) (First) (Middle)

101 MISSION STREET, SUITE 1000

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $1.52 to $1.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

2. The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

	/s/ Reid Hoffman	09/18/2025
	/s/ Frank Huang, Manager of Reprogrammed Interchange LLC	09/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for VOR report on 09/16/2025?

The Form 4 reports that Reprogrammed Interchange LLC sold 447,278 shares of Vor Biopharma common stock on 09/16/2025 at a weighted average price of $1.5401.

How many VOR shares does Reprogrammed Interchange LLC own after the sale?

After the reported transaction, Reprogrammed Interchange LLC beneficially owns 32,781,209 shares (reported as direct ownership).

What price range did the VOR trades occur at?

The explanatory note states trades occurred at prices ranging from $1.52 to $1.58; the filed price is the weighted average of those trades.

Does Reid Hoffman directly own the shares sold by Reprogrammed?

The filing states Reid Hoffman may be deemed a beneficial owner of Reprogrammed's shares due to shared control and indirect pecuniary interest, but he disclaims ownership except to the extent of his pecuniary interest.

When was the Form 4 signed?

The Form 4 bears signatures dated 09/18/2025 from Reid Hoffman and Frank Huang, Manager of Reprogrammed Interchange LLC.